Neuropathic pain is an entity that causes patient disability and its diagnosis and treatment is a challenge for physicians. In a significant percentage of patients with neuropathic pain, it is restricted to one dermatome or to a particular region of the body; in this case, it is referred to as localized neuropathic pain. There are no Mexican clinical guidelines proposing recommendations for the diagnosis and treatment of localized neuropathic pain in our population. This article presents the recommendations of a multidisciplinary consensus of specialists from different areas involved in the diagnosis and treatment of this type of patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.24875/GMM.19005195 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Successful Thoracic Spinal Cord Stimulator Implantation in a High-Risk Patient With Intractable Intercostal Neuralgia: A Case Report.
A A Pract
January 2025
From the Department of Pain Management, Cleveland Clinic, Cleveland, Ohio.
Intercostal neuralgia can be debilitating and extremely difficult to treat despite multi-modal therapies. The literature describing the role of neuromodulation in patients with intercostal neuralgia is scarce. In this medically challenging case report, we describe a 56-year-old male with a near complete resolution of intractable chronic intercostal neuralgia, secondary to traumatic rib fractures and multiple surgical interventions, with a single lead thoracic spinal cord stimulator (SCS) implant.
View Article and Find Full Text PDFPrescribing Patterns of Gabapentinoids in Chronic Pain Management: A Single Institution Retrospective Chart Review.
Psychopharmacol Bull
January 2025
Hasoon, Department of Anesthesiology, Critical Care, and Pain Medicine, The University of Texas Health Science Center at Houston, Tx.
Gabapentin and pregabalin are widely used in the management of neuropathic pain though their prescribing patterns, effectiveness, and safety profiles remain topics of ongoing research. This retrospective chart review analyzed the prevalence of gabapentinoid use in a chronic pain clinic over a one-year period from May 1, 2023, to April 30, 2024. The study examined patient records from four pain management physicians, focusing on those prescribed gabapentin or pregabalin.
View Article and Find Full Text PDFPCAT19: the role in cancer pathogenesis and beyond.
Front Cell Dev Biol
December 2024
Department of General Surgery, Nanchang Third Hospital, Nanchang, Jiangxi, China.
PCAT19, a long non-coding RNA, has attracted considerable attention due to its diverse roles in various malignancies. This work compiles current research on PCAT19's involvement in cancer pathogenesis and progression. Abnormal expression of PCAT19 has been observed in various cancers, and its correlation with clinical features and prognosis positions it as a promising prognostic biomarker.
View Article and Find Full Text PDFPerceptions of treatment, accompanying symptoms, and other problems in patients with chronic pain: a multicenter cross-sectional study in Korea.
Korean J Pain
January 2025
Department of Anesthesiology and Pain Medicine, Konkuk University School of Medicine, Seoul, Korea.
Article Synopsis
- Chronic pain significantly impacts patients' daily lives, mental health, and relationships, leading to various concerns about treatment and its side effects.
- The study involved 833 patients from South Korea, revealing that many expressed worries about medication risks and opioid addiction, with common symptoms including irritability, depression, and sleep disturbances.
- Analysis showed that women were more prone to anxiety and depression, while men faced issues like family conflict and unemployment, highlighting that younger patients experienced more accompanying symptoms than older ones.
Characterizing pain in Parkinson's disease: types, predictors, and management implications.
Korean J Pain
January 2025
Department of Neurology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkiye.
Article Synopsis
- The study investigates the high prevalence of pain in Parkinson's disease (PD) patients, with 80.6% reporting pain, indicating its significant impact on quality of life.
- It distinguishes between neuropathic pain (NP) and musculoskeletal pain, finding that longer disease duration predicts NP and that females experience more musculoskeletal pain.
- The research highlights the correlation between anxiety and central parkinsonian pain and suggests further exploration of amantadine's potential benefits in managing pain, emphasizing the need for personalized treatment approaches in PD.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!